نتائج البحث

Infliximab: Pharmacology, Uses and Limitations

• Authors : Medrano Acevedo, Antonio D.; Fajardo Gaitan, Montserrat

Subjects: Infliximab; Infliximab--Therapeutic use; Anti-inflammatory agentsMEDICAL / Immunology

تفاصيل العنوان

Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.

• Authors : Herrmann O; Department of Hematology Oncology Hemostaseology and Stem Cell Transplantation Faculty of Medicine, University Hospital RWTH Aachen, Pauwelsstr 30, 52074, Aachen, Germany.; Kuepper MK

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Infliximab/Infliximab/Infliximab/*therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy

• Source: BMC cancer [BMC Cancer] 2019 Jul 04; Vol. 19 (1), pp. 658. Date of Electronic Publication: 2019 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy.

• Authors : Ning L; Department of Gastroenterology, First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 310003, Zhejiang, China.; Li S

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/genetics ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/metabolism

• Source: BioMed research international [Biomed Res Int] 2019 Nov 22; Vol. 2019, pp. 1475705. Date of Electronic Publication: 2019 Nov 22 (Print Publication: 2019).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema.

• Authors : Lejoyeux R; a Ophthalmology Department, Reference Center for Rare Diseases OPTHARA, Pitié-Salpétrière Hospital , Paris VI University , Paris , France.; Diwo E

Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Infliximab/Infliximab/Infliximab/*therapeutic use

• Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2018; Vol. 26 (7), pp. 991-996. Date of Electronic Publication: 2018 Aug 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

• Authors : Salvador-Martín S; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.; Raposo-Gutiérrez I

Subjects: Adalimumab/Adalimumab/Adalimumab/*pharmacology ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*pharmacology

• Source: International journal of molecular sciences [Int J Mol Sci] 2020 May 09; Vol. 21 (9). Date of Electronic Publication: 2020 May 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.

• Authors : Zhao, Heng-Nan¹; Jiang, Min¹; Sun, Ming-Jun¹

Subjects: *STEROID drugs; *ULCERATIVE colitis; *DRUG efficacy

• Source: Saudi Journal of Gastroenterology. Jul/Aug2021, Vol. 27 Issue 4, p191-200. 10p.

تفاصيل العنوان

Infliximab-Related Infusion Reactions: Systematic Review.

• Authors : Lichtenstein L; Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, University of Tel Aviv, Israel .

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects ; Drug Hypersensitivity/Drug Hypersensitivity/Drug Hypersensitivity/*prevention & control ; Inflammatory Bowel Diseases/Inflammatory Bowel Diseases/Inflammatory Bowel Diseases/*drug therapy

• Source: Journal of Crohn's & colitis [J Crohns Colitis] 2015 Sep; Vol. 9 (9), pp. 806-15. Date of Electronic Publication: 2015 Jun 19.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.

• Authors : Principi M; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy. .; Losurdo G

Subjects: Quality of Life*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*administration & dosage ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*administration & dosage

• Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2015 Jun; Vol. 24 (2), pp. 165-70.Publisher:

تفاصيل العنوان

Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.

• Authors : Özer İ; Meram Faculty of Medicine, Department of Dermatology, Necmettin Erbakan University, Konya, Turkey.; Karaçin C

Subjects: Amyloidosis/Amyloidosis/Amyloidosis/*drug therapy ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Hidradenitis Suppurativa/Hidradenitis Suppurativa/Hidradenitis Suppurativa/*drug therapy

• Source: Dermatologic therapy [Dermatol Ther] 2017 Mar; Vol. 30 (2). Date of Electronic Publication: 2016 Nov 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effect of Infliximab and Adalimumab on Experimental Colitis Following Orally Supplemented Iron.

• Authors : Triantafillidis J; a Inflammatory Bowel Disease Unit, 'IASO General' Hospital , Athens , Greece.; Vagianos C

Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Inflammatory Bowel Diseases/Inflammatory Bowel Diseases/Inflammatory Bowel Diseases/*drug therapy

• Source: Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2017 Feb; Vol. 30 (1), pp. 6-12. Date of Electronic Publication: 2016 Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8809255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان